Tracking Respiratory Viruses in Pakistan (2022–2025): Genomic and Epidemiologic Insights from Sentinel Surveillance of Influenza, SARS-CoV-2, and RSV
Viruses · 23.12.2025 · 18 (1) · 26
DOI: 10.3390/v18010026 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Viruses, online erschienen am 23.12.2025. Verfasst von Nazish Badar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Laboratories Division, National Institute of Health, Chak Shahzad, Park Road, Islamabad 45500, Pakistan. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Global Influenza Hospital Surveillance Network.
Abstract (Originalsprache)
Influenza and other respiratory viruses pose significant public health threats among SARI patients, yet comprehensive surveillance data remain limited in Pakistan. This prospective, multi-center study characterized the burden, distribution, and molecular evolution of respiratory viruses among hospitalized SARI patients across seven tertiary hospitals from November 2022 to June 2025. Specimens were tested using RT-PCR for influenza, SARS-CoV-2, and RSV, with 375 samples sequenced via Oxford Nanopore Technology. Among 11,451 specimens, 2818 (24.6%) tested positive: RSV (1648, 14.4%), influenza (855, 7.5%; 45% H1N1pdm09, 35% H3N2, 20% influenza B), and SARS-CoV-2 (315, 2.8%). RSV predominantly affected children under 2 years (63%), while influenza and SARS-CoV-2 primarily impacted adults aged 15–40 years. Male predominance (65–79%) reflected healthcare access barriers. Strong winter seasonality (December–February) was observed for influenza and RSV. ICU admission rates were 17% for influenza, 16% for RSV, and 4% for SARS-CoV-2. Shortness of breath was associated with influenza (OR = 1.62) and RSV (OR = 1.27), while malaise (OR = 2.24) and myalgia (OR = 3.87) was associated with SARS-CoV-2. Phylogenetic analysis revealed vaccine-matched influenza clades and rapid SARS-CoV-2 variant succession (3–4 months). RSV is the primary SARI pathogen in young children, necessitating maternal vaccines and nirsevimab implementation. Sustained genomic surveillance remains essential for pandemic preparedness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Public Health Laboratories Division, National Institute of Health, Chak Shahzad, Park Road, Islamabad 45500, Pakistan.
- Saidu Group of Teaching Hospital, Pathology Department, Saidu Medical College, Swat 19200, Pakistan.
- Pathology Department, Nishtar Medical University, Multan 66000, Pakistan.
- National Institute of Health, Chak Shahzad, Park Road, Islamabad 45500, Pakistan.
Förderung
- Global Influenza Hospital Surveillance Network
Zitieren
APA
Badar, N., Ahad, A., Mirza, H. A., Hanan, F., Javaid, A., Amanat, A., Saghir, Z., & Salman, M. (2025). Tracking Respiratory Viruses in Pakistan (2022–2025): Genomic and Epidemiologic Insights from Sentinel Surveillance of Influenza, SARS-CoV-2, and RSV. Viruses, 18(1), 26. https://doi.org/10.3390/v18010026
Vancouver
Badar N, Ahad A, Mirza HA, Hanan F, Javaid A, Amanat A, et al. Tracking Respiratory Viruses in Pakistan (2022–2025): Genomic and Epidemiologic Insights from Sentinel Surveillance of Influenza, SARS-CoV-2, and RSV. Viruses. 2025;18(1):26. doi:10.3390/v18010026
BibTeX
@article{Badar2025,
author = {Badar, Nazish and Ahad, Abdul and Mirza, Hamza Ahmed and Hanan, Fazal and Javaid, Asghar and Amanat, Aamir and Saghir, Zunira and Salman, Muhammad},
title = {Tracking Respiratory Viruses in Pakistan (2022–2025): Genomic and Epidemiologic Insights from Sentinel Surveillance of Influenza, SARS-CoV-2, and RSV},
journal = {Viruses},
year = {2025},
volume = {18},
number = {1},
pages = {26},
doi = {10.3390/v18010026}
}
EUVIMED